IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Cesarean Delivery and Post-operative Pain Management With Local Anesthesia
This study has been completed.
Sponsor:
University of South Florida
Information provided by (Responsible Party):
University of South Florida
ClinicalTrials.gov Identifier:
NCT00298571
First received: February 28, 2006
Last updated: June 14, 2012
Last verified: February 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The use of .5% Bupivacaine with epinephrine at the time of skin closure in cesarean deliveries will decrease post-op pain.
| Condition | Intervention | Phase |
|---|---|---|
| Pain, Postoperative | Drug: .5% bupivacaine with epinephrine | Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by University of South Florida:
Primary Outcome Measures:
- 1. Decreased post-op pain
- 2. Decreased post-op narcotic use
Secondary Outcome Measures:
- improved hospital stay satisfaction
| Estimated Enrollment: | 100 |
| Study Start Date: | February 2006 |
| Study Completion Date: | October 2007 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | Child, Adult, Senior |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Pregnant Women with scheduled cesarean delivery
- able to perform informed consent
Exclusion Criteria:
- Labor
- chronic pain
- allergic to local anesthetic
- unable to perform informed consent
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00298571
Please refer to this study by its ClinicalTrials.gov identifier: NCT00298571
Locations
| United States, Florida | |
| Tampa General Hospital | |
| Tampa, Florida, United States, 33606 | |
Sponsors and Collaborators
University of South Florida
Investigators
| Study Director: | Shelly Holmstrom, MD | USF Department OB/Gyn |
More Information
| Responsible Party: | University of South Florida |
| ClinicalTrials.gov Identifier: | NCT00298571 History of Changes |
| Other Study ID Numbers: |
1212 |
| Study First Received: | February 28, 2006 |
| Last Updated: | June 14, 2012 |
Keywords provided by University of South Florida:
|
Cesarean Delivery Post-operative Pain Local Anesthetic |
Additional relevant MeSH terms:
|
Pain, Postoperative Pain Neurologic Manifestations Nervous System Diseases Postoperative Complications Pathologic Processes Signs and Symptoms Bupivacaine Epinephrine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents |
Peripheral Nervous System Agents Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic beta-Agonists Bronchodilator Agents Autonomic Agents Anti-Asthmatic Agents Respiratory System Agents Mydriatics Sympathomimetics Vasoconstrictor Agents |
ClinicalTrials.gov processed this record on June 23, 2017